Gadolinium MRI Lawyers

Gadolinium, or gadodiamide, is a contrast agent that was used to increase the contrast of blood vessels during MRI procedures so they can better be distinguished from surrounding tissue.

Gadolinium MRI Lawyers

While gadolinium served its purpose for MRI procedures, it is clear that nephrogenic systemic fibrosis or nephrogenic fibrosing dermopathy (NSF/NFD) can result from the use of a gadolinium contrast MRI in patients with kidney failure. First recognized as a disease in 1997, nephrogenic systemic fibrosis/ nephrogenic fibrosing dermopathy causes thickening or tightening of the skin and connective tissues, which inhibits the patient’s ability to move, and it also causes pain, muscle weakness, scarring of internal organs, and difficulty bending joints.

More than 215 cases of NSF/NFD have been documented in the last decade, but despite ongoing research, the cause of the disease was not entirely clear. Now, as many suspected, gadolinium-containing contrasting agents used for Magnetic Resonance Angiography (MRA) in patients with kidney failure is the culprit. In June 2006, the FDA first reported its belief that nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy can be caused by the use of gadolinium contrast MRI.

Last year, on May 23, 2007, FDA asked manufacturers to include a new black box warning on gadolinium contrast MRIs stating that patients with severe kidney insufficiency who receive gadolinium-based agents are at risk for developing (NSF/NFD). Additionally, the warning states that patients with liver problems are also at risk for developing (NSF/NFD) if they use a gadolinium based MRI.

There are five gadolinium-based contrast agents identified: Bayer’s gadopentetate dimeglumine (Magnevist); GE Healthcare’s gadodiamide, (Ominiscan, which seemed to have a good bit of market share);Mallinckrodt’s gadoversetamide (or OptiMARK); MultiHance’s gadobenate dimeglumine, (MultiHance), and Bracco Diagnostics’s gadoteridol (ProHance).

Gadolinium MRI NSF/NSD lawyers allege that these companies had superior knowledge and information regarding gadolinium and, accordingly, knew (or should have known) that gadolinium is toxic and harmful and would lead to serious injury and, accordingly, should have properly designed and tested the gadolinium MRI contrast.

We have settled the our client's cases in this litigation. Our last case settled in 2013.

Contact Us For a Free Consultation

If you are hurt in a serious accident or are the victim of medical malpractice, contact our team of lawyers to discuss your case.
Call us now for help at (800) 553-8082

You can also get a FREE no obligation on-line consultation.

Client Reviews

  • They quite literally worked as hard as if not harder than the doctors to save our lives.
    ★★★★★
  • Ron helped me find a clear path that ended with my foot healing and a settlement that was much more than I hope for.
    ★★★★★
  • Hopefully I won't need it again but if I do, I have definitely found my lawyer for life and I would definitely recommend this office to anyone!
    ★★★★★
  • The last case I referred to them settled for $1.2 million.
    ★★★★★
  • I am so grateful that I was lucky to pick Miller & Zois.
    ★★★★★
  • The entire team from the intake Samantha to the lawyer himself (Ron Miller) has been really approachable.
    ★★★★★
  • The case settled and I got a lot more money than I expected. Ron even fought to reduce how much I owed in medical bills so I could get an even larger settlement.
    ★★★★★
  • Miller and Zois is the best firm in the state of Maryland, and without their support, understanding, and just being there when I needed encouragement, I truly do not know how I would have succeeded without them.
    ★★★★★